Cannabis Use Reported by Patients Receiving Primary Care in a Large Health System
- PMID: 38837159
- PMCID: PMC11154156
- DOI: 10.1001/jamanetworkopen.2024.14809
Cannabis Use Reported by Patients Receiving Primary Care in a Large Health System
Abstract
Importance: Despite the changing legal status of cannabis and the potential impact on health, few health systems routinely screen for cannabis use, and data on the epidemiology of cannabis use, and especially medical cannabis use among primary care patients, are limited.
Objective: To describe the prevalence of, factors associated with, and reasons for past-3 month cannabis use reported by primary care patients.
Design, setting, and participants: This cross-sectional study used electronic health record data from patients aged 18 years and older who had an annual wellness visit between January 2021 and May 2023 from a primary care clinic within a university-based health system in Los Angeles, California.
Exposures: Factors of interest included age, race and ethnicity, sex, employment status, and neighborhood Area Deprivation Index (ADI).
Main outcomes and measures: Cannabis use was assessed using the Alcohol Substance Involvement Screening Test (ASSIST). Patients were also asked about reasons for use, symptoms for which they used cannabis, and mode of use.
Results: Among the 175 734 patients screened, the median (range) age was 47 (18-102) years; 101 657 (58.0%) were female; 25 278 (15.7%) were Asian, 21 971 (13.7%) were Hispanic, and 51 063 (31.7%) were White. Cannabis use was reported by 29 898 (17.0%), with 10 360 (34.7%) having ASSIST scores indicative of moderate to high risk for cannabis use disorder (CUD). Prevalence of cannabis use was higher among male patients than female patients (14 939 [20.0%] vs 14 916 [14.7%]) and younger patients (18-29 years, 7592 [31.0%]; ≥60 years, 4200 [8.5%]), and lower among those who lived in the most disadvantaged neighborhoods (ADI decile 9-10, 189 [13.8%]; ADI decile 1-2, 12 431 [17.4%]). The most common modes of use included edibles (18 201 [61.6%]), smoking (15 256 [51.7%]), and vaporizing (8555 [29.0%]). While 4375 patients who reported using cannabis (15.6%) did so for medical reasons only, 21 986 patients (75.7%) reported using cannabis to manage symptoms including pain (9196 [31.7%]), stress (14 542 [50.2%]), and sleep (16 221 [56.0%]). The median (IQR) number of symptoms managed was 2 (1-4), which was higher among patients who were at moderate to high risk for CUD (4 [2-6] symptoms).
Conclusions and relevance: In this study, cannabis use and risk of CUD were common, and more than three-quarters of patients who reported any cannabis use reported doing so to manage a health-related symptom. These findings suggest that integration of information regarding cannabis use for symptom management could help provide a crucial point-of-care opportunity for clinicians to understand their patients' risk for CUD.
Conflict of interest statement
Figures
Similar articles
-
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.JAMA Netw Open. 2023 Aug 1;6(8):e2328934. doi: 10.1001/jamanetworkopen.2023.28934. JAMA Netw Open. 2023. PMID: 37642968 Free PMC article.
-
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375. JAMA Netw Open. 2021. PMID: 33956129 Free PMC article.
-
Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.JAMA Netw Open. 2022 Nov 1;5(11):e2239772. doi: 10.1001/jamanetworkopen.2022.39772. JAMA Netw Open. 2022. PMID: 36318205 Free PMC article.
-
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.JAMA Netw Open. 2022 May 2;5(5):e2211677. doi: 10.1001/jamanetworkopen.2022.11677. JAMA Netw Open. 2022. PMID: 35604691 Free PMC article.
-
State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.JAMA Psychiatry. 2023 Apr 1;80(4):380-388. doi: 10.1001/jamapsychiatry.2023.0019. JAMA Psychiatry. 2023. PMID: 36857036 Free PMC article.
Cited by
-
Self-Medication Paths: A Descriptive Study Unveiling the Interplay Between Medical and Nonmedical Cannabis in Chronic Pain Management.Clin J Pain. 2024 Nov 1;40(11):635-645. doi: 10.1097/AJP.0000000000001241. Clin J Pain. 2024. PMID: 39192773 Free PMC article.
-
Cannabis Use Among Older Adults.JAMA Netw Open. 2025 May 1;8(5):e2510173. doi: 10.1001/jamanetworkopen.2025.10173. JAMA Netw Open. 2025. PMID: 40366653 Free PMC article.
-
Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patients.Cancer Causes Control. 2025 Jul;36(7):719-724. doi: 10.1007/s10552-025-01972-x. Epub 2025 Feb 12. Cancer Causes Control. 2025. PMID: 39934610 Free PMC article.
References
-
- Substance Abuse and Mental Health Services Administration . 2021 NSDUH annual national report. January 4, 2023. Accessed April 29, 2024. https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous